3 Drugmakers Most Likely to Launch Coronavirus Vaccines in the U.S. by the End of 2020

President Trump thinks that a COVID-19 vaccine could be ready before the end of the year. He's even optimistic that a vaccine could be available around the time of the U.S. election on Nov. 3, 2020. Is this merely wishful thinking? Maybe not.

The U.S. Food and Drug Administration (FDA) recently scheduled an advisory committee meeting for Oct. 22, 2020, to "discuss the general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19." The agency also said that it's "prepared to rapidly schedule additional meetings of this committee upon submission of any applications as appropriate." In addition, FDA Commissioner Stephen Hahn stated in an interview with the Financial Times that he's willing to fast-track emergency use authorization (EUA) of a COVID-19 vaccine even before phase 3 testing has completed. 

Add all of this up, and we've got a real possibility that one or more coronavirus vaccines could be available in the U.S. by the end of 2020. But which ones? 

Continue reading

Source Fool.com